UBS Group AG - DERMATA THERAPEUTICS INC ownership

DERMATA THERAPEUTICS INC's ticker is and the CUSIP is 249845108. A total of 12 filers reported holding DERMATA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of DERMATA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$15,296
+91.2%
37,308
+152.1%
0.00%
Q3 2022$8,000
+14.3%
14,798
+32.0%
0.00%
Q2 2022$7,000
+40.0%
11,207
+159.2%
0.00%
Q1 2022$5,000
+400.0%
4,323
+2187.3%
0.00%
Q3 2021$1,0001890.00%
Other shareholders
DERMATA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 637,147$414,0000.01%
Sage Capital Advisors,llc 12,000$8,0000.00%
UBS Group AG 11,207$7,0000.00%
WELLS FARGO & COMPANY/MN 11,023$7,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,666$17,0000.00%
CITIGROUP INC 48,942$32,0000.00%
TUDOR INVESTMENT CORP ET AL 10,205$7,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,496$7,0000.00%
Citadel Advisors 79,969$52,0000.00%
View complete list of DERMATA THERAPEUTICS INC shareholders